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Cartilage defects are a major health problem. Tissue engineering has developed different strategies and several
biomaterial morphologies, including natural-based ones, for repairing these defects. We used electrospun
polycaprolactone (PCL) and starch-compounded PCL (SPCL) nanofiber meshes to evaluate extracellular matrix
(ECM) formation by bovine articular chondrocytes (BACs). The main aim of this work was to evaluate the
suitability of PCL and SPCL nanofiber meshes in chondrocyte cultures, and their capability to produce ECM
when seeded onto these nanostructured materials. The effect of culture conditions (static vs dynamic) on ECM
formation was also assessed. BACs were seeded onto PCL and SPCL nanofiber meshes using a dynamic cell-
seeding procedure and cultured under static or dynamic conditions for 4 weeks. Constructs were characterized
using scanning electron microscopy, histology, immunolocalization of collagen types I and II, and glycosami-
noglycan (GAG) quantification. Results show an extensive cell colonization of the entire nanofiber mesh, for both
materials, and that chondrocytes presented typical spherical morphology. Some degree of cell infiltration inside
the nanofiber meshes was noticeable for both materials. ECM formation and GAG were detected throughout the
materials, evidencing typical construct maturation. PCL and SPCL nanofiber meshes are suitable as supports for
ECM formation and therefore are adequate for cartilage tissue-engineering approaches.
Introduction
Joint diseases due to cartilage degeneration are a majorhealth problem for people of all ages, but particularly for
elderly people. Osteoarthritis, for example, affects 80% of
people aged 60 and older. One therapeutic option is non-
steroidal antiinflammatory drug treatment aimed at the de-
lay and control of cartilage loss.1 Other options involve
surgical procedures, such as arthroplasty with implantation
of joint prosthesis.2 These procedures are able to improve
joint function considerably, although the patients’ mobility
may be limited, and some problems at the interface of bone
and implant may arise, causing the need for revision.2 Al-
though surgical outcome is good initially, durability of so-
lutions and improvement of patients’ quality of life is far
from ideal. Tissue engineering represents an alternative route
to current treatments. Its strategy may be based in cell in-
jections into the defect and fixation with a membrane3 or
implantation of combinations of cells, scaffolds, and growth
factors4 that may result in extracallular matrix (ECM) pro-
duction.
Articular hyaline cartilage is an avascular tissue that covers
the joint and acts as a load-bearing and wear-control struc-
ture. Because cartilage is subjected to mechanical stimulus
in its natural environment, a strategy to regenerate cartilage
under the action of similar stimulus is typically followed.
It has been shown in vitro that the culture environment greatly
affects chondrocyte proliferation in a three-dimensional scaf-
fold.5 Bioreactors, including spinner-flasks, rotating-wall
vessels, and direct perfusion, are designed to provide a con-
trolled environment for tissue-engineered cartilage produc-
tion.6 Biomaterial morphology,7 as well as culture conditions
and cell source,8 can also influence the quality of tissue-
engineered cartilage constructs.
Biodegradable biomaterials, either natural or synthetic,
have been processed into scaffolds for tissue engineering.9,10
Polycaprolactone (PCL) is a biodegradable polymer that be-
longs to the aliphatic polyester family. Currently, this class of
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materials is among the most attractive polymers that meet
various medical and physical demands for safe clinical appli-
cations. PCL is used in clinical practice as a biomaterial because
of its good mechanical properties; its ability to form com-
patible blends and copolymers with a wide range of other
polymers, including natural-based polymers; low toxicity;
biocompatibility; and biodegradability.11–13 In addition, its
composition with starch offers new opportunities for control-
ling its degradation kinetics,14 release of growth factors, and
new surface chemistry.15,16 Starch-compounded PCL (SPCL)
combines the affinity of starch and the processability and
mechanical properties of the synthetic polymer (PCL).17 Sev-
eral experimentswithSPCLhavebeenconductedwith cells, for
instance, in osteoblast-like cells,18 mesenchymal stem cells,19,20
and leukocytes.21 Dynamic culture conditions22 and in vivo
implantation in murine animal models23 were also explored.
Electrospinning allows for the production of polymeric
ultrafine fibers with diameters ranging from a few microns to
tens of nanometers.24 Because of their small diameter, poly-
meric nanofibers exhibit unusual properties, such as high
specific surface area, flexibility in surface functionality, and
superior mechanical properties.25 Additionally, nonwoven
mesh structures produced by electrospinning physically mi-
mic the structure and morphology of ECM components of
a large variety of native tissues, including bone and carti-
lage.26–28 The aim of the present study was to assess ECM
formation in PCL and SPCL electrospun nanofiber meshes,
evaluating the effect of starch on the material formulation and
the effect of static or dynamic culture conditions.
Materials and Methods
Nanofiber meshes processing
Polymeric solutions of PCL (PCL 787, TONE polymer,
Union Carbide Chemicals and Plastics Division, Bound
Brook, NJ, with 80 kDa) and SPCL (30% starch, 70% PCL;
Novamont: SPCL, Mater-BI ZI01U, Novamont, Novara, Italy)
were prepared by dissolving the polymer or the blend into an
organic solvent mixture of chloroform:dimethylformamide
70:30 (Sigma-Aldrich, Dorset, U.K.), at concentrations of 17%
and 24% (w=v), respectively. Polymeric solutions were placed
into syringes with blunted metallic needles with an internal
diameter of 0.8mm attached. The syringe was coupled to a
syringe pump (model KDS100, KD Scientific, Holliston, MA)
to control the solution flow rate. A high-voltage power supply
(0–25 kV) was applied to the needle to generate the electric
field. Aluminum foil connected to a ground was used as the
fiber mesh collector. The capillary tip-to-collector distance
and the flow rate were fixed at 20 cm and 1.0mL=h, respec-
tively. Nanofiber mesh production lasted 1 h and required
1mL of polymeric solution. The applied voltage was main-
tained at 9 kV. Nanofiber meshes were collected and cut into
1-cm2 squares. Experiments were all performed at room
temperature, and the conditions were optimized for the two
materials.
Isolation of bovine articular chondrocytes and culture
on nanofiber meshes
Isolation and expansion of bovine articular chondro-
cytes (BACs) was performed according to a method previ-
ously reported.29 Cells were cultured with expansion
medium: high-glucose Dulbecco’s modified Eagle medium
(Sigma D-5671), containing 10mM of 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid buffer (Sigma H-0887),
L-alanyl-L-glutamine (Sigma G-8541), nonessential amino
acids (Sigma M-7145), 10,000 units=mL of penicillin, 10,000
mg=mL of streptomycin (Sigma P-0781), 10% fetal calf serum
(Biosera S1810, East Sussex, UK), and 10 ng=mL of basic fi-
broblast growth factor (bFGF) (PeproTech 100–18B, Rocky
Hill, NY). Dynamic cell seeding was performed using Petri
dishes. Three nanofiber meshes were placed in each Petri
dish and cells suspension added to have 6.5!106 cells per
nanofiber mesh. We used 20 nanofiber meshes per experi-
mental condition for each material. Petri dishes were placed
in a rotator, inside the incubator, at 60 rpm for 72 h.
After 72 h, cell seeding was complete, and half of the con-
structs were kept in the rotator (dynamic conditions), whereas
the others were placed in the incubator (static conditions).
Differentiation medium (expansion medium without bFGF
and with 1mg=mL of insulin (Sigma Co.) and 1mg=mL of
ascorbic acid, Sigma A-4544) was changed every 3 days.
Samples were taken at 1, 2, 3, and 4 weeks of culture.
Scanning electron microscopy
For scanning electron microscopy (SEM) analysis, nanofi-
ber meshes were collected at 1, 2, 3, and 4 weeks; washed in
sterile phosphate buffered saline (PBS); and immersed in 3%
glutaraldehyde (Sigma G-5882) with 0.1M cacodylate buffer
at pH 7.4 (AGARR1103, Essex, England) at room temperature
for 1 hour. Afterwards, they were washed in PBS, osmium
tetra oxide was added, and they were left for 2 h. Finally,
samples were dehydrated in crescent alcohol concentrations
and left to dry. SEMmicrographs were taken at different time
periods and with several magnifications.
Histological analysis
Samples were collected at the end of the experiment, placed
in optimal cutting temperature compound (BDH, Gurr, Lut-
terworth, Leicestershire, England), and stored at "208C. Sec-
tions were cut 8mm thick, placed in microscopy slides, fixed
for 30min at 48C in a fresh 4% paraformaldehyde (Sigma
P-6148) solution in PBS buffer, washed twice in distilledwater,
and left overnight to air-dry. Slides were stored at 48C until
they were used for staining procedures. Hematoxylin and
eosin (H&E) staining was conducted in an automatic ma-
chine (Fume Cupboard; X219=E11=LEV1, UK). Sections were
washed in runningwater for 5min and then dipped in 1% acid
alcohol for 5 to 10 s. They were washed again in water and
stained in eosin for 10min. Another washing with water was
performed, for 5min, after sections were dehydrated through
crescent concentrations of alcohol, cleared in xylene, and
mounted in dinbutyphthalate and xylene (DPX) (BDH 36029
2F). Toluidine blue staining was also performed. Staining
solution was prepared by adding 1% of toluidine blue (Sigma
T-0394) dissolved in distilled water containing 0.5g of sodium
borate, followed by filtering. One drop of this solution was
added to each section for 2 to 3 s. Then sections were rinsed
with distilled water and left to air dry. They were cleared in
xylene and mounted in DPX. Alcian blue staining was per-
formed by rinsing the sections in 3% acetic acid and keeping
them in 1%Alcian blue solution (Sigma A-3157) for 18h. After
that, the stain was poured off, and sections were counter-
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stained with aqueous neutral red (Sigma N-6634) for 1min.
Sections were washed with water, left to dry, rinsed in ab-
solute alcohol, cleared in xylene, and mounted in DPX.
Immunolocalization of type I and II collagens
Immunolocalization of type I and type II collagens was
performed in fixed sections. Sections were pretreated in
10mg=mL of hyaluronidase (Sigma Co.) for 30min at 378C
and in 2mg=mL of pronase (Fluka=Sigma Co.) for 30min at
378C. Sections were washed in PBS, and endogenous peroxi-
dase activity was quenched with 3% hydrogen peroxide in
50% methanol (BDH 101586 6B) for 5min. Sections were
washed in Tris-buffered saline (TBS) and blocked with 3%
bovine serum albumin (Sigma A-2153) in TBS=Tween 20
(Sigma Ultra P-7949) for 1 h to avoid nonspecific staining.
Sections were further incubated with primary antibodies
(collagen type I and collagen type II;goat antitype I collagen
UNLB 1310–01 and Goat antitype II collagen UNLB 1320–01)
overnight at 48C, in a humidified atmosphere. Then sections
were washed once with high-salt wash solution and twice in
TBS=Tween 20 for 10min each and then incubated with sec-
ondary antibody from the kit for 1 h at room temperature,
again in a humidified atmosphere. The remaining protocol is
as described in the Vectastain Elite ABC Kit PK-6105 (Vector
Laboratories Ltd, Peterborough, UK) and in the Vector DAB
Kit (Vector Laboratories Ltd). Slides were washed in water for
5min and then counterstained with hematoxylin for nuclei
visualization. Finally, slides were mounted in DPX. Controls
were performed using normal goat serum instead of primary
antibodies, which was also included in the kit.
Dimethylmethylene blue assay
for glycosaminoglycan quantification
Samples were collected at 4 weeks of culture, freeze-dried
overnight, and then digested. Digestion solution was pre-
pared by adding papain (Sigma, P-4762) and N-acetyl cyste-
ine (Sigma A-8199) at concentrations of 0.05% and 0.096%,
respectively, to 50mL of digestion buffer (200mM of phos-
phate buffer containing 1mM ethylenediaminetetraacetic
acid (Sigma E-5134), pH 6.8). Samples were incubated with
600 mL of the solution overnight at 608C. Afterwards, they
were centrifuged at 13000 rpm for 10min. Supernatant was
collected and stored at "208C until the assay was performed.
Dimethymethylene blue (DMB) stock solution was prepared
by dissolving 16mg of DMB powder in 900mL of distilled
water containing 3.04 g of glycine and 2.73 g of sodium chlo-
ride. pH was adjusted to 3.0 with hydrochloric acid and
volume to 1L. The solution was stored at room temperature
covered by aluminum foil. Chondroitin sulfate (Sigma C-
8529) solution was prepared in water in a 5-mg=mL stock
solution and kept refrigerated. Dilutions of this solution were
made to make a standard curve. Samples were also diluted as
appropriate using distilled water. Optical density was mea-
sured in a microplate reader at 530 nm. Unseeded nanofiber
meshes were used as controls and were treated in the same
way as the seeded ones for the GAG assay procedure. We
used three per GAG assay.
Statistical analysis
Data from triplicates of GAG quantification are presented
as averages# standard errors. One-way analysis of variance
in conjunction with Turkey’s test was also performed.
Results
SEM observations of nanofiber meshes produced show a
random distribution of nanofibers, as expected. This is the
typical result of the electrospining process, caused by the elec-
tric field generated in the equipment (Fig. 1). PCL nanofiber
meshes were composed of nanofibers with diameters in the
submicron range, from 0.4 to 1.4 mm (Fig. 1A). The average
pore size of PCL nanofiber meshes was 72.67# 31.48mm.
Conversely, the SPCL nanofiber meshes presented a larger
dispersion of nanofiber diameters (the thinner had diameters
*0.3–20mm), probably because of the insolubility of the
starch phase in the organic solvent mixture used. A PCL so-
lution containing a suspension of colloidal starch particles
was obtained, and this has important implications for fiber
diameter and mesh morphology. The average pore size of
SPCL, evaluated from SEM micrographs of the nanofiber
meshes, was 65.21# 22.07mm.
SEM micrographs (Fig. 2) show that cells colonized both
types of nanofibermeshes, in both culture conditions, covering
their surface extensively and homogeneously. PCL nanofiber
meshes keep their membrane-like shape (Fig. 2A–C, G–I),
whereas SPCL nanofiber meshes tend to curl in a tubular
structure (Fig. 2D–F, J–L). This structure trapped a consider-
able number of cells inside. Chondrocytes kept their round
morphology throughout the experiment in PCL (Fig. 2A, B,
G–I) and SPCL (Fig. 2E, F, K) nanofiber meshes under both
culture conditions. BACs attached and spread not only to the
nanofiber meshes surface, but also in the inner regions of
the mesh structure, as can be observed with H&E staining
FIG. 1. Electron micro-
graphs of (A) poly-
caprolactone (PCL) and (B)
starch-compounded PCL
nanofiber meshes processed
using electrospinning.
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(Fig. 3A, D, G, J). PCL and SPCL nanofiber meshes showed
similar cell distribution, as well as the presence of proteogly-
cans, as shown by toluidine blue (Fig. 3B, E, H, K) and Alcian
blue staining (Fig. 3C, F, I, L). Darker Alcian blue staining can
be seen better in histological sections from static culture con-
ditions (Fig. 3C, F) than in dynamic conditions (Fig. 3I, L). This
result indicates the presence of more sulfated proteoglycans in
static conditions. SPCL nanofiber meshes curled and formed
tubes, entrapping a considerable number of cells inside. There
were a large amount of proteoglycans in these protected inner
regions, as well as collagen type I and type II (data not shown).
Both collagens types were also detected in static (Fig. 4A–F)
and dynamic culture conditions (Fig. 4G–L). Collagen type
I was more evident in sections prepared from SPCL nanofiber
meshes (both culture conditions) (Fig. 4E, K) than in sections
from PCL nanofiber meshes (Fig. 4B, H), indicating that this
combination of structure and material generated a predomi-
nance of fibrocartilage.
FIG. 2. Bovine articular chondrocyte (BAC) growth morphology in polycaprolactone (PCL) and starch-compounded PCL
(SPCL) nanofiber meshes at different time points of the experiment (14 days (A, D, G, J), 21 days (B, E, H, K), and 28 days
(C, F, I, L)) under static (A–F) or dynamic (G–L) culture conditions. Different magnifications were used to highlight cell
morphology. Cell growth was identical in static culture conditions for PCL (A–C) or SPCL (D–F) nanofiber meshes. The same
was observed in dynamic culture conditions for PCL (G–I) and SPCL (J–L).
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Quantification of GAGs in PCL nanofiber meshes revealed
the presence of approximately 2.0% of total GAGs in the ECM
in static culture conditions, versus 0.8% of total GAGs found
in dynamic conditions (Fig. 5). No statistically significant
difference was found between these results ( p> 0.05). As for
the SPCL nanofiber meshes, results revealed 2.4% of total
GAGs for the static cultures, versus 1.1% for the dynamic
ones. Again, there was not a statistically significant difference
between static and dynamic cultures ( p> 0.05). The same lack
of statistical significance was found in differences between
results obtained with the two types of materials ( p> 0.05).
Discussion
Themain goal of designing and producing a new scaffold is
to provide a bettermicroenvironment for cells in an attempt to
substitute the natural ECM milieu while they expand and
repair the tissue. Many materials have been proposed for
FIG. 3. Production of extracellular matrix in polycaprolactone (PCL) and starch-compounded PCL (SPCL) nanofiber meshes
at 4 weeks of culture under static (A–F) and dynamic (G–L) culture conditions. Cells were able to attach to the nanofibers
structure, as shown with hematoxylin and eosin staining, for PCL (A, G) and SPCL (D, J). Cells penetrated this structure and
produced proteoglycans, detected using toluidine blue staining, in PCL (B, H) and SPCL (E, K) nanofiber meshes. Sulphated
proteoglycans were detected using Alcian blue staining, for PCL (C, I) and SPCL (F, L) nanofiber meshes. Two magnifications
(10x and 20x) were used at each staining for microscopic observation. Scale bar¼ 100 mm. Arrows highlight nanofiber mesh
structure. Color images available online at www.liebertonline.com=ten.
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scaffold production. Of those, natural polymers such as
starch14,16–23,27,30–38 and biodegradable polyesters, for exam-
ple, PCL,11,13,17,39–41 have been developed. In this case, an
electrospinning techniquewas used to explore thosematerials
and obtain a new SPCL fibrous structure. Electrospinningwas
used to produce meshes that were intended to provide good
conditions for BACs to produce ECM. Polymer nanofibers
have recently been used in the fields of biotechnology and
biomedicine.42 Several tissue-engineering approaches, aiming
at bone11,32,43 and cartilage40,41 regeneration, have also been
explored. SEM micrographs confirmed that cells were able to
colonize both nanofiber meshes, reinforcing the idea that PCL
and SPCL are suitable polymers for the intended purpose.17
BACs attached and spread not only at the surface of the
FIG. 4. Immunolocalization of collagens in polycaprolactone (PCL) and starch-compounded PCL (SPCL) nanofiber meshes
at 4 weeks of culture under static (A–F) and dynamic (G–L) culture conditions. Controls (A, D, G, J) were performed with
normal goat serum. Under static conditions, collagen type I was detected only for SPCL (E) nanofiber meshes. Collagen type
II, alternatively, was detected for PCL (C) and SPCL (F) nanofiber meshes. Under dynamic conditions, collagen type I and
type II were detected in PCL (H, I) and SPCL (K, L) nanofiber meshes. Two magnifications (10!and 20!) were used at each
staining for microscopic observation. Scale bar¼ 100 mm. Arrows highlight nanofiber mesh structure. Color images available
online at www.liebertonline.com=ten.
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nanofiber meshes, but also in the inner regions of the mesh
structure, as can be observed with H&E staining. Our present
results indicate that BACs penetrate the structure, colonizing
it and using it as a support for cell activity. This is, to the
best of our knowledge, an encouraging result, because most
of the studies with nanofiber meshes obtained using elec-
trospinning do not show so clear a penetration of cells into
the mesh structure.25 Cells were able to produce ECM, as
shown by toluidine and Alcian blue staining, which detected
GAG accumulation. Collagen type I and II were both de-
tected, expression of collagen type I being greater in SPCL
meshes. Collagen type I is associated with fibrocartilage
tissue,44 which is undesirable when articular cartilage is the
goal of a regeneration strategy. PCL electrospun nanofiber
meshes have been proposed as novel scaffolds for tissue en-
gineering,45 especially for cartilage repair. Li et al. showed the
production of cartilaginous matrix with fetal bovine chon-
drocytes seeded onto PCL nanofibrous scaffolds, highlighting
the importance of these materials for proliferation and
maintenance of the chondrocyte phenotype.41 Recent work
from the same authors also show the versatility of these na-
nofibrous scaffolds in sustaining chondrogenic differentiation
of human mesenchymal stem cells.40,46
GAG production was not statistically different in the two
types of materials. There was a slightly difference between
them, being higher in SPCL than in PCL (2.4% vs 2.0%). SPCL
is a blend composed of corn starch and polycaprolactone that
has been extensively studied as a biomaterial for different
biomedical applications.17,27,31,47 It was recently reported that
it supports BAC adhesion, proliferation, and differentiation in
SPCL fiber-based scaffolds.47 It was unexpected to find more
GAGs in static cultures than in dynamic ones, because chon-
drocytes are naturally subjected to a fluid flow microenvi-
ronment and therefore could be stimulated by these culture
conditions.48 The use of mechanical force can be employed in
their culturing process to produce a phenotypically correct
tissue,49 although it needs to replicate relevant physiologic
conditions. Agitation was used during culture to produce a
phenotipically adequate tissue, but it may be concluded that
these conditions were not sufficient. We can hypothesize that
the higher GAG content in static cultures observed in this
study was due to some GAGs being released into the culture
medium during the experiment when the culture medium
was mixed. Furthermore, seeding in spinner flasks may have
somehow caused some cell damage, due to the turbulent flow
generated by the magnetic stirring.50 Similar results were
obtained with bovine calf chondrocytes seeded onto fibrous
polyglycolic acidmeshes, where constructs exposed to similar
mixing synthesized and released more GAGs into the culture
medium and resulted in lower fractions of GAGs.51 Another
study showed thatmixingmay increase the loss of GAGs from
the construct, decreasing pericellular GAG concentration.52
Data did not allow us to substantiate clearly which of the
materials is best for the approach used in this work. It is
known that a suitable scaffold for tissue engineering must
have good surface properties, which will allow cell attach-
ment and efficient transport of nutrients to growing cells. In
that sense, a highly hydrophilic material would allow greater
water uptake and, consequently, a greater nutrient supply to
cells.53,54 PCL is more hydrophobic, whereas SPCL is more
hydrophilic, which is more advantageous for cell growth than
PCL. PCL is a homopolymer with slow degradation kinetics.
It is in clinical use for many applications and could be the
biodegradable material of choice, although a wide range of
options for the development of PCL has already been ex-
plored. One additional alternative to develop its performance
being proposed herein is to compound it with other biode-
gradable materials, those compounds offering a new range of
tunable properties. If we accept that there are advantages to
working with a natural-based polymer, the combination of
starch with PCL may lead to an attractive combination of
properties that may be tailored to specific applications, in-
cluding cartilage tissue engineering. This material has been
extensively studied for biomedical applications because of its
biocompatibility and biodegradability14,16,18,27,33,55 and po-
tential of inducing low levels of inflammatory response.21
Its degradation kinetics can be controlled using material
composition, having a more hydrophilic character and en-
abling the design of controlled-release systems for growth
factors.56 Results indicate that SPCL may be slightly more
effective in sustaining ECMproduction, but it was also shown
that greater expression of collagen type I may be detrimental
in obtaining hyaline cartilage from BACs cultured in these
meshes. Further optimization of this material will be ad-
dressed to overcome this limitation.
Conclusion
The aim of this work was to determine whether a blend of
starch with PCL (SPCL) would have similar performance in
sustaining BAC growth and ECM production as PCL. PCL
and SPCL electrospun nanofibermesheswere both interesting
structures for cartilage tissue-engineering strategies. PCL and
SPCL nanofiber meshes seeded dynamically evidenced a
good response for this purpose. An interesting result was the
evidence that chondrocytes proliferated in external regions
and showed some capacity to migrate into inner regions of
both types of fiber meshes. BACs were able to produce ECM
under static or dynamic culture conditions. Static culture
conditions lead to enhanced ECM production. These obser-
vations were confirmed by staining of proteoglycans, im-
munolocalization of collagens type I and type II, and GAG
detection.
In this work, we confirmed evidence from the litera-
ture that sustain the claim that PCL nanofiber meshes are
suitable for tissue-engineering approaches and also pro-
pose a new scaffold for cartilage tissue engineering (SPCL
FIG. 5. Glycosaminoglycan (GAG) quantification for poly-
caprolactone (PCL) and starch-compounded PCL (SPCL)
nanofiber meshes at 4 weeks of culture. Static culture con-
ditions are represented in white, dynamic culture conditions
in gray.
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nanofiber meshes). The data did not show obvious qualitative
or quantitative differences between the two materials; nev-
ertheless, we consider it advantageous to use SPCL, not only
because of its natural-based composition, but also because it
allows for greater control of the degradation kinetics and
further functionalization of its structure. It is our under-
standing that both materials have a role to play in cartilage
regeneration strategies and that, in particular, SPCL nano-
fiber meshes can be further enhanced, not only in terms of
degradability, but also by providing opportunities for local
release of growth factors for articular cartilage tissue-
engineering strategies.
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